Drugs / ADSVF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04387825 | Aug 2015 → May 2019 | systemic sclerosis | National Institute of Medical Sciences and Nutrition Salvador Zubiran | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADSVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04387825 ↗ |
| Modality | Cell therapy | “mixed cell fraction obtained by enzymatic digestion of adipose tissue, termed adipose-derived stromal vascular fraction (ADSVF)” NCT04387825 ↗ |
| Route | Subcutaneous | “10 ml distributed subcutaneously throughout the palm of the hand” NCT04387825 ↗ |